L'intérêt à découvert sur Celldex Therapeutics Inc (NASDAQ:CLDX) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 7.08M à 7.40M. Cela représente 13.16% des actions disponibles au public de l'entreprise.
L'intérêt à découvert pour Celldex Therapeutics Corp (XNAS:CLDX) a diminué au cours de la dernière période de référence, passant de 280,30 M à 275,20 M. Cela a mis 1,17 % des actions de la société disponibles au public en position courte.
Sur la base du volume moyen récent de 960.98K actions échangées par jour, il faudrait 7.7 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
CLDX | Celldex Therapeutics, Inc. | 10/15/2025 | 10/24/2025 | 13.16% | 56,190,428 | 7,395,696 | 960,982 | 7.7 | |
CLDX | Celldex Therapeutics, Inc. | 09/30/2025 | 10/09/2025 | 12.61% | 56,190,428 | 7,083,741 | 1,174,444 | 6.03 | |
CLDX | Celldex Therapeutics, Inc. | 09/15/2025 | 09/24/2025 | 11.71% | 56,190,428 | 6,581,143 | 1,482,997 | 4.44 | |
CLDX | Celldex Therapeutics, Inc. | 08/29/2025 | 09/10/2025 | 12.84% | 56,190,428 | 7,214,984 | 1,763,380 | 4.09 | |
CLDX | Celldex Therapeutics, Inc. | 08/15/2025 | 08/26/2025 | 13.01% | 56,190,428 | 7,312,348 | 1,181,040 | 6.19 | |
CLDX | Celldex Therapeutics, Inc. | 07/31/2025 | 08/11/2025 | 13.85% | 56,190,428 | 7,781,241 | 890,155 | 8.74 | |
CLDX | Celldex Therapeutics, Inc. | 07/15/2025 | 07/24/2025 | 15.07% | 56,190,428 | 8,469,593 | 990,480 | 8.55 | |
CLDX | Celldex Therapeutics, Inc. | 06/30/2025 | 07/10/2025 | 14.01% | 56,190,428 | 7,873,818 | 1,120,201 | 7.03 | |
CLDX | Celldex Therapeutics, Inc. | 06/13/2025 | 06/25/2025 | 13.93% | 56,190,428 | 7,828,519 | 1,284,825 | 6.09 | |
CLDX | Celldex Therapeutics, Inc. | 05/30/2025 | 06/10/2025 | 14.90% | 56,190,428 | 8,370,585 | 1,090,380 | 7.68 | |
CLDX | Celldex Therapeutics, Inc. | 05/15/2025 | 05/27/2025 | 16.24% | 56,190,428 | 9,127,147 | 744,502 | 12.26 | |
CLDX | Celldex Therapeutics, Inc. | 04/30/2025 | 05/09/2025 | 16.03% | 56,190,428 | 9,009,066 | 641,049 | 14.05 | |
CLDX | Celldex Therapeutics, Inc. | 04/15/2025 | 04/25/2025 | 15.63% | 56,180,378 | 8,779,950 | 992,432 | 8.85 | |
CLDX | Celldex Therapeutics, Inc. | 03/31/2025 | 04/09/2025 | 14.47% | 57,399,833 | 8,303,305 | 748,063 | 11.1 | |
CLDX | Celldex Therapeutics, Inc. | 03/14/2025 | 03/25/2025 | 15.94% | 57,399,833 | 9,151,823 | 817,555 | 11.19 | |
CLDX | Celldex Therapeutics, Inc. | 02/28/2025 | 03/11/2025 | 15.46% | 57,399,833 | 8,875,878 | 641,501 | 13.84 | |
CLDX | Celldex Therapeutics, Inc. | 02/14/2025 | 02/26/2025 | 16.03% | 57,360,258 | 9,192,670 | 859,800 | 10.69 | |
CLDX | Celldex Therapeutics, Inc. | 01/31/2025 | 02/11/2025 | 15.47% | 57,360,258 | 8,873,582 | 790,546 | 11.22 | |
CLDX | Celldex Therapeutics, Inc. | 01/15/2025 | 01/27/2025 | 14.78% | 57,360,258 | 8,480,235 | 1,366,662 | 6.21 | |
CLDX | Celldex Therapeutics, Inc. | 12/31/2024 | 01/10/2025 | 14.11% | 57,303,618 | 8,086,627 | 816,361 | 9.91 | |
CLDX | Celldex Therapeutics, Inc. | 12/13/2024 | 12/24/2024 | 12.75% | 57,303,618 | 7,308,344 | 981,184 | 7.45 | |
CLDX | Celldex Therapeutics, Inc. | 11/29/2024 | 12/10/2024 | 13.44% | 57,303,618 | 7,701,959 | 1,092,436 | 7.05 | |
CLDX | Celldex Therapeutics, Inc. | 11/15/2024 | 11/26/2024 | 13.67% | 57,303,618 | 7,834,833 | 1,125,324 | 6.96 | |
CLDX | Celldex Therapeutics, Inc. | 10/31/2024 | 11/11/2024 | 14.38% | 57,303,618 | 8,239,830 | 964,822 | 8.54 | |
CLDX | Celldex Therapeutics, Inc. | 10/15/2024 | 10/24/2024 | 14.65% | 57,303,618 | 8,397,350 | 825,066 | 10.18 | |
CLDX | Celldex Therapeutics, Inc. | 09/30/2024 | 10/09/2024 | 14.50% | 57,303,618 | 8,306,171 | 2,238,280 | 3.71 | |
CLDX | Celldex Therapeutics, Inc. | 09/13/2024 | 09/24/2024 | 14.68% | 57,303,618 | 8,410,054 | 676,406 | 12.43 | |
CLDX | Celldex Therapeutics, Inc. | 08/30/2024 | 09/11/2024 | 14.96% | 57,303,618 | 8,571,341 | 565,510 | 15.16 | |
CLDX | Celldex Therapeutics, Inc. | 08/15/2024 | 08/26/2024 | 15.12% | 57,303,618 | 8,661,767 | 641,780 | 13.5 | |
CLDX | Celldex Therapeutics, Inc. | 07/31/2024 | 08/09/2024 | 14.65% | 57,303,618 | 8,397,023 | 854,334 | 9.83 | |
CLDX | Celldex Therapeutics, Inc. | 07/15/2024 | 07/24/2024 | 12.98% | 56,926,570 | 7,390,703 | 535,183 | 13.81 | |
CLDX | Celldex Therapeutics, Inc. | 06/28/2024 | 07/10/2024 | 12.27% | 56,926,570 | 6,986,016 | 923,588 | 7.56 | |
CLDX | Celldex Therapeutics, Inc. | 06/14/2024 | 06/26/2024 | 11.29% | 56,926,570 | 6,427,891 | 681,537 | 9.43 | |
CLDX | Celldex Therapeutics, Inc. | 05/31/2024 | 06/11/2024 | 11.01% | 56,926,570 | 6,265,519 | 611,742 | 10.24 | |
CLDX | Celldex Therapeutics, Inc. | 05/15/2024 | 05/24/2024 | 11.62% | 56,926,570 | 6,615,448 | 570,736 | 11.59 | |
CLDX | Celldex Therapeutics, Inc. | 04/30/2024 | 05/09/2024 | 12.28% | 56,926,570 | 6,989,589 | 594,972 | 11.75 | |
CLDX | Celldex Therapeutics, Inc. | 04/15/2024 | 04/24/2024 | 11.86% | 56,926,570 | 6,749,943 | 625,549 | 10.79 | |
CLDX | Celldex Therapeutics, Inc. | 03/28/2024 | 04/09/2024 | 11.44% | 57,323,242 | 6,557,945 | 781,261 | 8.39 | |
CLDX | Celldex Therapeutics, Inc. | 03/15/2024 | 03/26/2024 | 10.29% | 57,323,242 | 5,897,116 | 1,512,575 | 3.9 | |
CLDX | Celldex Therapeutics, Inc. | 02/29/2024 | 03/11/2024 | 11.18% | 57,323,242 | 6,411,060 | 1,400,499 | 4.58 | |
CLDX | Celldex Therapeutics, Inc. | 02/15/2024 | 02/27/2024 | 14.60% | 47,525,242 | 6,940,941 | 673,142 | 10.31 | |
CLDX | Celldex Therapeutics, Inc. | 01/31/2024 | 02/09/2024 | 14.49% | 46,313,760 | 6,710,607 | 676,912 | 9.91 | |
CLDX | Celldex Therapeutics, Inc. | 01/12/2024 | 01/24/2024 | 13.44% | 46,313,760 | 6,223,447 | 640,823 | 9.71 | |
CLDX | Celldex Therapeutics, Inc. | 12/29/2023 | 01/10/2024 | 14.23% | 46,313,760 | 6,588,315 | 551,681 | 11.94 | |
CLDX | Celldex Therapeutics, Inc. | 12/15/2023 | 12/27/2023 | 15.87% | 46,313,760 | 7,351,541 | 654,764 | 11.23 | |
CLDX | Celldex Therapeutics, Inc. | 11/30/2023 | 12/11/2023 | 17.43% | 46,313,760 | 8,070,265 | 779,448 | 10.35 | |
CLDX | Celldex Therapeutics, Inc. | 11/15/2023 | 11/27/2023 | 17.02% | 46,313,760 | 7,882,546 | 1,657,012 | 4.76 | |
CLDX | Celldex Therapeutics, Inc. | 10/31/2023 | 11/09/2023 | 14.45% | 38,888,760 | 5,619,561 | 489,149 | 11.49 |
À la recherche des actions les plus vendues à découvert?